cbdMD Inc. (YCBD) Operatsion marja

cbdMD Corp (YCBD) - korporativ logo

cbdMD, Inc. insonlar va hayvonlar uchun yuqori sifatli CBD mahsulotlarini sotish orqali daromad keltiradi. Operatsion foyda differensiali ushbu tendentsiyani tasdiqlaydi va uning joriy qiymati -13.90 ni tashkil etadi. Muvaffaqiyat bevosita onlayn savdo va kannabis qonunchiligiga nisbatan moslashuvchanlik bilan bog'liq. Biroq, mijozlar bazasining stagnatsiyasi va FDA tomonidan B2B tarmog'ini kengaytirishga qo'yilgan taqiqlar, "kulrang bozor" ishtirokchilarining bosimi tufayli ekotizimning rivojlanishini cheklamoqda.

YCBD - cbdMD Inc. Operatsion foyda normasi 04.07.2022 - 19.11.2026 oraligʻida

cbdMD Inc. (YCBD) kompaniyasining tahliliy kesimlari

- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi tafsilotlari:
Kompaniyaning har tomonlama tahlili:cbdMD Corp
cbdMD asosiy tovari

cbdMD, Inc. (YCBD) kompaniyasining kredit sifatini baholash uchun tahlilchi operatsion marjani ko'rib chiqadi, bu esa soliqlar va foizlardan oldingi umumiy tushumga nisbatan asosiy biznes operatsiyalaridan olingan foyda ulushini aks ettiradi. Qayd etilgan operatsion marja CBD sektoridagi kuchaygan narxlar raqobati va brendning narx belgilash imkoniyatlarining pasayishi kompaniyani mahsulot narxlarini tushirishga majbur qilayotganini, bu esa o'z navbatida operatsion samaradorlikni kamaytirayotganini ko'rsatadi.

Raqobatchilar tahlili

Operatsion rentabellik haleon.com|Operatsion rentabellik KVUE|Operatsion rentabellik Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operatsion foyda bo'yicha marjinallik|Operatsion marja LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operatsion rentabellik|PRGO - Operatsion rentabellik|Alvotech Corp (ALVO) - Sotuvning operatsion marjasi|LQDA: Operatsion marja|Sotuvning operatsion rentabelligi glpg.com (GLPG)|Operatsion rentabellik ANI Pharmaceuticals Inc|MNKD: Operatsion foyda normasi|Sotuvning operatsion marjasi AMPH (Amphastar)|PCRX - Sotuvning operatsion rentabelligi|Operatsion marja SPRY (ars-pharma.com)|Operatsion foyda normasi TBPH|Aquestive Therapeutics, Inc. - Operatsion marja|scpharmaceuticals.com - Operatsion foyda koeffitsiyenti|Tectonic (TECX) - Operatsion rentabellik|Sotuvning operatsion marjasi Tonix Pharmaceuticals Inc.|Operatsion rentabellik sxtchina.com|Sotuvning operatsion marjasi Eupraxia Pharmaceuticals (EPRX)|Operatsion marja BHST|EXOZ - Sotuvning operatsion rentabelligi|Oramed - Sotuvning operatsion marjasi|Entera Bio Ltd. (ENTX) - Sotuvning operatsion rentabelligi|HYFT - Operatsion rentabellik|ABVC: Operatsion rentabellik|CPIX: Operatsion marja|Quantum BioPharma Ltd. - Operatsion foyda normasi|FGEN (FibroGen Corp) - Operatsion marja|Telomir Pharma (TELO) - Operatsion faoliyat rentabelligi|Operatsion rentabellik Rani Therapeutics Inc (RANI)|SNYR (Synergy CHC Corp.) - Operatsion foyda normasi|Operatsion rentabellik Rallybio Corporation RLYB|LEXX: Operatsion foyda bo'yicha sotuv rentabelligi|PULM - Operatsion rentabellik|Operatsion foyda normasi PTHL (Pheton Holdings)|Aptorum (APM) - Operatsion rentabellik|LYRA (Lyra Therapeutics) - Operatsion rentabellik|Operatsion rentabellik Impact BioMedical Inc|TNF Pharmaceuticals - Operatsion foyda marjasi|Operatsion marja PRFX|CYTO - Sotuvning operatsion rentabelligi|Operatsion rentabellik Lipella LIPO|Operatsion foyda koeffitsiyenti OPTN (OptiNose, Inc.)|PIRS - Operatsion rentabellik|Procaps (PROC) - Sotuvning operatsion marjasi|PTPI: Operatsion marja|Qilian International (QLI) - Operatsion marja|Operatsion rentabellik Acelyrin, Inc.|Operatsion marja TFF Pharmaceuticals, Inc.